These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 21351141)

  • 1. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
    Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
    J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.
    Abdallah BM; Ditzel N; Mahmood A; Isa A; Traustadottir GA; Schilling AF; Ruiz-Hidalgo MJ; Laborda J; Amling M; Kassem M
    J Bone Miner Res; 2011 Jul; 26(7):1457-71. PubMed ID: 21308776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive regulation of osteogenesis by bile acid through FXR.
    Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
    J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
    Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
    J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).
    Sottile V; Seuwen K; Kneissel M
    Calcif Tissue Int; 2004 Oct; 75(4):329-37. PubMed ID: 15549648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased trabecular bone formation in mice lacking the growth factor midkine.
    Neunaber C; Catala-Lehnen P; Beil FT; Marshall RP; Kanbach V; Baranowsky A; Lehmann W; Streichert T; Ignatius A; Muramatsu T; Schinke T; Amling M
    J Bone Miner Res; 2010 Aug; 25(8):1724-35. PubMed ID: 20200993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
    Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
    Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.
    Nakanishi R; Akiyama H; Kimura H; Otsuki B; Shimizu M; Tsuboyama T; Nakamura T
    J Bone Miner Res; 2008 Feb; 23(2):271-7. PubMed ID: 17907918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
    Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
    J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency.
    Schiltz C; Marty C; de Vernejoul MC; Geoffroy V
    J Cell Biochem; 2008 Aug; 104(5):1803-17. PubMed ID: 18384129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
    Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
    PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
    Wang L; Liu S; Quarles LD; Spurney RF
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schnurri-2 deficiency counteracts against bone loss induced by ovariectomy.
    Nagao M; Saita Y; Hanyu R; Hemmi H; Notomi T; Hayata T; Nakamoto T; Nakashima K; Kaneko K; Kurosawa H; Ishii S; Ezura Y; Noda M
    J Cell Physiol; 2011 Mar; 226(3):573-8. PubMed ID: 21069746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblast deletion of exon 3 of the androgen receptor gene results in trabecular bone loss in adult male mice.
    Notini AJ; McManus JF; Moore A; Bouxsein M; Jimenez M; Chiu WS; Glatt V; Kream BE; Handelsman DJ; Morris HA; Zajac JD; Davey RA
    J Bone Miner Res; 2007 Mar; 22(3):347-56. PubMed ID: 17147488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice.
    Kim J; Xing W; Wergedal J; Chan JY; Mohan S
    Physiol Genomics; 2010 Jan; 40(2):100-10. PubMed ID: 19887580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
    Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
    Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation.
    Koyama H; Nakade O; Takada Y; Kaku T; Lau KH
    J Bone Miner Res; 2002 Jul; 17(7):1219-29. PubMed ID: 12096835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.
    Cao J; Venton L; Sakata T; Halloran BP
    J Bone Miner Res; 2003 Feb; 18(2):270-7. PubMed ID: 12568404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-7 influences osteoclast function in vivo but is not a critical factor in ovariectomy-induced bone loss.
    Lee SK; Kalinowski JF; Jacquin C; Adams DJ; Gronowicz G; Lorenzo JA
    J Bone Miner Res; 2006 May; 21(5):695-702. PubMed ID: 16734384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.